Skip to main content
Figure 4 | Orphanet Journal of Rare Diseases

Figure 4

From: Agalsidase alfa in pediatric patients with Fabry disease: a 6.5-year open-label follow-up study

Figure 4

Estimated glomerular filtration rate (eGFR; mL/min/1.73 m 2) over time in the transition safety population. (a) Individual patients and (b) mean (± SD) change from baseline; the dotted line represents the annualized slope. Baseline mean ± SD eGFR values at the beginning of phase 1 were 123.29 ± 16.00 mL/min/1.73 m2 (measured at study TKT023 week 25/26). Agalα, agalsidase alfa; CI, confidence interval; eGFR, estimated glomerular filtration rate; SD, standard deviation; yr, year.

Back to article page